Isomeric composition of tetracycline antibiotics in liquid manure at a swine animal feeding operation in iowa

Isomeric Composition of Tetracycline Antibiotics in Liquid Manure at a Swine Animal
Feeding Operation in Iowa
M. T. Meyer, Ed Lee, U.S. Geological Survey, 4821 Quail Crest Pl., Lawrence, KS 66049 D.W. Kolpin, Kent Beecher, U.S. Geological Survey, 400 S. Clinton St., Iowa City, IA 52244 Abstract

Analytical methods used for environmental assessments of tetracycline antibiotics may redistribute the
proportion of the parent antibiotics and their epimers and isomers in liquid waste and water. In previous studies,
chlortetracycline and tetracycline have been reported as the sum of the parent compounds and their epimers and
isomers. In order to determine concentrations of parent compounds, epimers, and isomers individually, on-line
solid-phase extraction and liquid chromatography/mass spectrometry with standard addition was used to
characterize liquid waste samples collected from swine lagoons. Antibiotic residues were measured in liquid
waste collected from the north and south sides of a lagoon in July, October, and November 2003 at a swine
animal feeding operation in Iowa. The lagoon was drained between the October and November samplings.
Addressed
The primary antibiotic detected was chlorotetracycline and the dominant isomeric species of chlorotetracycline
found were iso-chlorotetracycline, iso-epi-chlorotetracycline, and epi-chlorotetracycline. The concentrations
ranged from 1,200 µg/L to 4,600 µg/L for iso-chlorotetracycline, 1,100 µg/L to 2,700 µg/L for iso-epi-
chlorotetracycline, and<0.1 to 92 µg/L for epi-chlorotetracycline. Chlorotetracycline was detected in three of
six samples at concentrations from <0.1 to 1,400 µg/L. Tetracycline and epi-tetracycline were detected in all
the samples at concentrations from 71 to 210 µg/L. Anhydro-tetracycline, a degradate of tetracycline, was
detected at concentrations of <0.1 to 2.4 µg/L. Lincomycin was detected in concentrations from 0.9 to 44 µg/L.
Spatial and temporal variations in concentrations were measured and will be discussed. More importantly, to
understand the environmental distribution and fate of the tetracycline antibiotics and the relation between
antibiotic residues and antibiotic-resistant bacteria, the isomeric species as well as the parent antibiotic need to
be measured.
Biographical Sketches
Michael T. Meyer, PhD., U.S. Geological Survey
Michael Meyer has been a Research Geochemist for the U.S. Geological Survey (USGS) since 1988. He
received his Ph.D. in Geology from the University of Kansas in 1994. His research has focused on the
development of methods for the analysis of emerging organic contaminants (e.g. herbicide metabolites and
pharmaceuticals) and determining their occurrence, fate, and geochemical transport in the environment.
Currently he is Director of the USGS, Kansas District, Organic Geochemistry Research Laboratory.
Dana Kolpin is a research hydrologist and has worked for the USGS since 1984. His research interests include
the occurrence of pesticides, pharmaceuticals, and other emerging contaminants in the environment.
  • Antibiotic and Disinfectant Resistant Bacteria in Rivers of the United States
  • Transport and Attenuation of Pharmaceuticals and Pesticide Residues During Bank Filtration and Their Relevance for Drinking Water Supply in Berlin, Germany
  • Pharmaceuticals, Musk Fragrances and Estrogens: Removal in Wastewater and Drinking Water Treatment
  • Pharmaceuticals and Other Organic Wastewater Contaminants in Water Resources of the United States: Research by the U.S. Geological Survey's Toxics Substances Hydrology Program
  • Occurrence and Fate of Antibiotics in Sewage, Surface, and Ground Water in Berlin, Germany
  • Assessment of the Transport Behavior of Pharmaceuticals in Surface Water and Artificially Recharged Ground Water
  • Fate of Organic Wastewater-Related Contaminants in a Drinking-Water-Treatment Plant
  • Screening Level Study of Pharmaceuticals in Septic Tank Effluent and City Sewage
  • Survey of the New York City Watershed for the Presence of Pharmaceuticals
  • Comparison of the Estrogen Levels and Endocrine Disruption in Philippine Lakes and the Great Lakes
  • Source and Fate of Pharmaceuticals and Selected Organic Wastewater Compounds in the Blue River Basin, Metropolitan Kansas City, USA
  • The Fate of Nonylphenol and Total Estrogenic Activity During Wastewater Treatment and Sludge Digestion: A Mass Balance Analysis
  • Occurrence of Emerging Organic Chemicals in Onsite Wastewater System Effluents
  • Persistence of Pharmaceuticals and Other Wastewater Related Compounds
  • Natural Attenuation of Organotin Compounds: Field and Laboratory Evidence
  • Preliminary Evidence for the Occurrence of Pharmaceuticals and Wastewater Compounds in a Karstic Aquifer Near a Spray Field
  • Fate of Organic Wastewater Contaminants: A Lagrangian Based Comparison Between High and Low Gradient Streams
  • Roles of Partitioning and Phototransformation in Predicting the Fate and Movement of Pharmaceuticals in UK and U.S. Rivers
  • Factors Controlling the Presence of Organic Wastewater Compounds in Urban Streams, Atlanta, Georgia
  • Occurrence and Fate of Pharmaceuticals in the Santa Ana River, California
  • Occurrence of Organic Wastewater Compounds and Antibiotic Residuals in Selected Ozark Streams, USA
  • Concentrations of Organic Compounds in Wastewater at Five Sites in New York State, 2003
  • Temporal Occurrence and Persistence of Pharmaceuticals, Pathogens, and Other Wastewater Compounds in an Effluent-Dependent Stream, Tucson, Arizona
  • Pharmaceuticals and Other Organic Wastewater Contaminants in Waste, Surface, Ground, and Drinking Waters of Minnesota
  • Preliminary Evaluation of Organic Wastewater Contaminants in Septic Tanks for Possible Use as Effluent Tracers in Shallow Ground Water
  • Pharmaceuticals and Hormones as Potential Ground Water Contaminants from On-Site Wastewater-Treatment Systems
  • Analysis and Fate of Human and Veterinary Pharmaceuticals in Water and Sediment
  • Combination of Multi-Component Methods for Ultra-Trace Determination of Neutral and Acidic Pharmaceutical Residues and Water
  • Analysis of Iodinated X-ray Contrast Media by Ion Chromatography with Inductively Coupled Plasma-Mass Spectrometry
  • Analysis of Veterinary Antibiotics and Their Degradation Products in Ground Water Using Liquid Chromatoghrapy Tandem Mass Spectrometry
  • Isomeric Composition of Tetracycline Antibiotics in Liquid Manure at a Swine Animal Feeding Operation in Iowa
  • Application of a Bioluminescent Estrogen Year-Reporter System for Determining the Estrogenic Activity in Water and Sediment Samples at a Superfund Site
  • Pharmaceuticals and Personal Care Products in Solids: Analysis and Field Results for Sediment, Soil, and Biosolid Samples
  • Occurrence of Antibiotics in Drinking Water
  • Selection of Antibiotics: A Chemometric Approach
  • Occurrence of Antibiotics, Pharmaceuticals and Sterols at Select Surface and Wastewater Sites in Iowa
  • Long Term Monitoring of the Occurrence of Antibiotic Residues and Antibiotic Resistance Genes in Groundwater near Swine Confinement Facilities
  • Environmental Fate and Effects of Ciprofloxacin in Estuarine Sediments
  • Sorption of Ciprofloxacin to Hydrous Oxides of Iron and Aluminum
  • Incorporation of Human and Veterinary Pharmaceuticals Into Natural Organic Matter: Studies With Model Compounds
  • Behavior of Trace Pollutants During Bank Filtration and Ground Water Recharge of Wastewater-impacted Surface Waters
  • Adsorption of Sulfonamide Antimicrobials to Clay Minerals
  • Assessing the Impact of Different Redox Conditions and Residence Times on the Fate of Organic Micropollutants During Riverbank Filtration
  • Quantitative Assessments of Trace Level Contaminants Using Inorganic Mixing Tracers
  • Relevance and Environmental Risk Assessment of Pharmaceutical Residues from Hospitals
  • Hormonal Parameters of Ecohydrology
  • Pollution Prevention: Risk Management of Pharmaceuticals Entering POTWs and Municipal Landfills from Routine Hospital Waste Management Practices
  • Veterinary Pharmaceuticals: Potential Environmental Impact and Treatment
  • Removal Efficiencies of Unregulated Trace Organics by Reverse Osmosis and Nanofiltration Membranes
  • Removal of Phenazone-type Pharmaceuticals and Their Metabolites During Drinking Water Treatment
  • Treatment of Endocrine Disruptor Compounds in Aqueous Solution with Accelerated Electron Injection
  • Conventional and Advanced Water Treatment Processes for the Removal of Endocrine Disruptors and Pharmaceuticals
  • Innovative Treatment and Cost-effective Bioremediation and Removal of EDCs: A Comparison of Conventional and Non-conventional Municipal Wastewater Treatment Processes
  • Anti-Estrogen Activity in Wastewater Effluent: Fate During Soil Aquifer Treatment
  • Photodegradation of Pharmaceutical and Contrast Media Agents in Surface Water by Direct Photolysis and UV Advanced Oxidation Processes
  • Impact of Pure Oxygen Nitrification Treatment on Removal of Antibiotic Residues and Patterns of Antibiotic Resistance in Reclaimed Water
  • Combining Bioassays and Chemical Analyses to Evaluate Removal of Endocrine Disruptors from Water Reclamation Facilities
  • Presence and Behavior of Wastewater-derived Pharmaceuticals in Soil Samples Irrigated by Reclaimed Water
  • Characterization of Pharmaceuticals, Selected Organic Wastewater Compounds, and Biological Communities in The Blue River Basin, Metropolitan Kansas City, USA
  • Source: http://www.iatp.org/files/64_2_37597.pdf

    Q205_latvia.indd

    Report Q205 Exhaustion of IPRs in cases of recycling and repair of goods Questions Analysis of the current statutory and case laws In your country, is exhaustion of IPRs provided either in statutory law or under case law with respect to patents, designs and trademarks? Exhaustion of IPRs is provided in statutory law for patents, designs and trademarks. What legal provisions are appl

    Lyme questionniare

    Martin Ross, M.D. Tara Nelson, N.D. The Healing Arts Partnership 4744 41st Ave. S.W., Ste. 102; Seattle, WA 98116 Name _______________________________________________________ Date _______________________ E-mail __________________________________ Home Phone (____)_______________________________ Cell Phone (____) _________________________Work Phone (____) ______________________________

    Copyright © 2010-2018 Pharmacy Drugs Pdf